-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
X4 Pharmaceuticals, Inc quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2017 to Q1 2024.
- X4 Pharmaceuticals, Inc Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $62K, a 51.2% decline year-over-year.
- X4 Pharmaceuticals, Inc annual Depreciation, Depletion and Amortization for 2023 was $419K, a 18.3% decline from 2022.
- X4 Pharmaceuticals, Inc annual Depreciation, Depletion and Amortization for 2022 was $513K, a 2.81% increase from 2021.
- X4 Pharmaceuticals, Inc annual Depreciation, Depletion and Amortization for 2021 was $499K, a 42.2% increase from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)